ClinicalTrials.gg
Not yet recruitingNCT07648108UDJ-TCAUpdated Jun 15, 2026

Evaluation of a Day Hospital Program for Adolescents and Young Adults With Eating Disorders

An interventional study of Day Hospital Multidisciplinary Care and Standard Care Outside Day Hospital Program in Eating Disorders, Nervosa Adolescent and Adolescent Eating Disorders, sponsored by Fondation Santé des Étudiants de France. Not yet recruiting. Open to participants aged 12 Years to 22 Years. Per ClinicalTrials.gov, last updated 2026-06-15.

Sponsored by Fondation Santé des Étudiants de France · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
307
Allocation
Non-randomized
Ages
12 Years to 22 Years
Sex
All
01

Study summary

This study aims to evaluate the clinical, psychological, and functional outcomes of adolescents with anorexia nervosa receiving multidisciplinary care in hospital settings. Participants are treated either in a day hospitalization program or in a full-time inpatient program, in accordance with the French national guidelines (Haute Autorité de Santé, HAS) for the management of anorexia nervosa.

The study seeks to better understand the evolution of patients' health status over time, including nutritional, psychological, and social dimensions, and to identify factors associated with treatment response. Data will be collected as part of routine clinical care without modification of the standard therapeutic management.

The results of this study may help improve clinical practices and optimize care pathways for adolescents with anorexia nervosa.

02

Conditions studied

  • Eating Disorders
  • Nervosa Adolescent
  • Adolescent Eating Disorders
03

In context

Feeding and Eating Disorders

645 studies on the registry are indexed under Feeding and Eating Disorders; 153 are open to participants now.

This study's planned enrollment of 307 is above the median of 71 across 452 interventional studies indexed under Feeding and Eating Disorders.

Browse Feeding and Eating Disorders studies →

Lead sponsor

Fondation Santé des Étudiants de France is the lead sponsor of 9 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 22 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adolescents and young adults aged 12 to 22 years
  • Diagnosed with an eating disorder
  • Referred for admission to the day hospital program between October 2019 and December 2023
  • Provided (and parental consent for minors)

Exclusion criteria

Exclusion Criteria:

  • Refusal to participate
  • Age below 12 years or above 22 years
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
307 participants (estimated)

Study arms

  • Other
    Day Hospital Program

    Participants admitted to a specialized multidisciplinary day hospital program for eating disorders.

    Other: Day Hospital Multidisciplinary Care

  • Other
    Non-Admitted Participants

    Participants who requested admission but were not admitted to the day hospital program.

    Other: Standard Care Outside Day Hospital Program

Interventions

  • OtherDay Hospital Multidisciplinary Care

    Participants admitted to the day hospital receive a multidisciplinary treatment program including psychiatric, medical, nutritional, and psychosocial care, delivered through structured daytime sessions without overnight stay.

  • OtherStandard Care Outside Day Hospital Program

    Participants not admitted to the day hospital program receive usual care according to standard clinical pathways outside the specialized day hospital setting.

06

What researchers measure

Primary outcomes

  1. Change in Body Mass Index (BMI)

    Time frame: From admission request to at least 18 months follow-up

Secondary outcomes

  1. Change in eating disorder psychopathology assessed by EDE-Q

    Eating disorder psychopathology will be assessed using the Eating Disorder Examination Questionnaire (EDE-Q), a self-report scale ranging from 0 to 6, with higher scores indicating more severe symptoms. The assessment will be performed at admission and discharge.

    Time frame: Baseline (at admission), discharge (end of hospitalization), and follow-up at least 18 months after admission

  2. Change in body image concerns assessed by BSQ

    Body image concerns will be assessed using the Body Shape Questionnaire (BSQ), a self-report scale with higher scores indicating greater body dissatisfaction. The assessment will be performed at admission and discharge.

    Time frame: Baseline (at admission), discharge (end of hospitalization), and follow-up at least 18 months after admission

  3. Change in anxiety and depression symptoms assessed by HADS

    Anxiety and depression symptoms will be assessed using the Hospital Anxiety and Depression Scale (HADS), which includes subscales for anxiety and depression, each ranging from 0 to 21, with higher scores indicating greater symptom severity. The assessment will be performed at admission and discharge.

    Time frame: Baseline (at admission), discharge (end of hospitalization), and follow-up at least 18 months after admission

  4. Change in obsessive-compulsive symptoms assessed by MOCI

    Obsessive-compulsive symptoms will be assessed using the Maudsley Obsessive-Compulsive Inventory (MOCI), where higher scores indicate more severe symptoms. The assessment will be performed at admission and discharge.

    Time frame: Baseline (at admission), discharge (end of hospitalization), and follow-up at least 18 months after admission

  5. Change in eating disorder-related quality of life assessed by EDQoL

    Quality of life related to eating disorders will be assessed using the Eating Disorders Quality of Life (EDQoL) questionnaire, with higher scores indicating greater impairment. The assessment will be performed at admission and discharge

    Time frame: Baseline (at admission), discharge (end of hospitalization), and follow-up at least 18 months after admission

  6. Change in autistic traits assessed by AQ-10

    Autistic traits will be assessed using the Autism Spectrum Quotient (AQ-10), a brief screening tool with higher scores indicating more pronounced autistic traits. The assessment will be performed at admission and discharge

    Time frame: Baseline (at admission), discharge (end of hospitalization), and follow-up at least 18 months after admission

  7. Change in family functioning assessed by FAD-12

    Family functioning will be assessed using the Family Assessment Device (FAD-12), with higher scores indicating poorer family functioning. The assessment will be performed at admission and discharge.

    Time frame: Baseline (at admission), discharge (end of hospitalization), and follow-up at least 18 months after admission

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for May 2026; primary completion for Feb 2027, 8 months later.

Of 269 non-industry interventional studies with no phase under Feeding and Eating Disorders, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 49. This study's planned 8 months is below that.

Counting every sponsor, half of 274 studies reached it within 28 months; a quarter within 14 and three quarters within 49.

How these figures are worked out, and which studies are left out of them.

Registered
May 12, 2026
First posted
Jun 15, 2026
StartEst.
May 25, 2026
Primary completionEst.
Feb 24, 2027
CompletionEst.
Feb 24, 2027
Last update
Jun 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07648108
Lead sponsor
Fondation Santé des Étudiants de France
Responsible party
Sponsor
First posted
Jun 15, 2026
Start date
May 25, 2026 (estimated)
Primary completion
Feb 24, 2027 (estimated)
Completion
Feb 24, 2027 (estimated)
Last update
Jun 15, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion